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 Chronic Swallowing Ability in Nasopharyngeal Cancer Survivors  
 after Radiotherapy with or without Chemotherapy 
 
 So Kwok Ho 
 Abstract 
In light of the lack of multidimensional data of long-term swallowing functions in nasopharyngeal 
cancer (NPC) survivors, the current study investigated NPC survivors’ long-term swallowing 
dysfunctions after radiotherapy or chemoradiation by a multidimensional protocol and explored 
their relationships with demographic and treatment-related variables. Twenty-seven participants 
were recruited and assessed through oromotor assessment, fiberoptic endoscopic evaluation of 
swallowing and quality-of-life questionnaires. Nearly half of the participants had oromotor deficits 
(47.6%) and penetration in at least one of the swallowing trials  (45.8%). All participants had 
pharyngeal residue in valleculae and most participants have residue in pyriform sinuses (81.8%) in 
at least one of the swallowing trials. Limitations in the activity and participation domains were 
prevalent though large variation in functioning was noted. Comparison between groups indicated 
that participants treated with concurrent chemotherapy have significantly less degree of penetration 
or aspiration and less residue in valleculae on oral trials for extra thick liquid than those treated 
with radiotherapy alone. Correlation analysis indicated that degree of penetration in thin liquid, 
mildly thick liquid and amount of residue residing on valleculae in extra thick liquid increase with 
the number of years since completion of radiotherapy. Functioning in the activity and participation 
domains also decreased with time since completion of radiotherapy. Regression analysis indicated 
that number of years since completion of radiotherapy was a significant predictor for pharyngeal 
residue. The deteriorating trend identified provided evidence to the need of continuous monitoring 
in swallowing functions in nasopharyngeal cancer survivors. Further research to identify risk 
factors for long-term swallowing problems and ways to minimize long-term swallowing problems  
are neededfor early identification and maximising swallowing functions for nasopharyngeal cancer 
survivors.  
 
Keywords: Chronic swallowing functions, nasopharyngeal cancer, radiotherapy, chemotherapy 
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Nasopharyngeal cancer (NPC) is particularly common in the Chinese population when 
compared with other parts of the world (Yu & Yuan, 2002). According to the latest statistics in 
Hong Kong Cancer Registry, NPC is the 7th most common cancer and ranked 7th in mortality rate 
among cancer types in 2011. There are 632 male and 230 female new cases in the year of 2011. 
Incidence rate for NPC is 12.2 per 100,000 in the population. Currently, radiotherapy with or 
without chemotherapy is the main treatment method for NPC. The overall survival rate after 
radiotherapy or chemoradiation was found to be 75% in a 5 year post-treatment period (Lee et 
al., 2005). Previous study has found that about 75% NPC survivors experienced dysphagia after 
radiotherapy (Hughes et al., 2000). Despite the prevalence of dysphagia reported for 
nasopharyngeal cancer survivors, there is a paucity of data on the chronic swallowing outcome 
as assessed by multidimensional outcome measures which is specific for nasopharyngeal cancer 
survivors.  
Dysphagia symptoms previously identified for head and neck cancer survivors included 
reduced airway protection, delayed swallow initiation uncoordinated swallowing, reduced 
swallowing efficiency and silent aspiration (Eisbruch et al., 2002; Lazarus et al., 1996; Nguyen 
et al., 2004). Impact of head and neck cancer treatment on swallowing-related quality-of-life was 
also reported in Nguyen et al. (2005). Some pathophysiological explanations have been given to 
the swallowing outcomes in the population. For one, radiotherapy-induced insufficient saliva 
production, or xerostomia, contributes to the swallowing difficulties by impairing the lubrication 
of food bolus, which is important for food transition. In addition, radiotherapy may induce 
fibrosis or neuromuscular incoordination to the pharyngeal constrictors and other swallowing-
related structures. This impairs the pharyngeal functions and hence reduces laryngeal clearance 
and laryngeal closure (Hughes et al, 1999), leading to aspiration which can be fatal.  
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Previous studies have also identified a number of risk factors associated with dysphagia 
in head-and-neck cancer survivors, including older age, advanced T-stage, bilateral neck 
irradiation, weight loss prior to radiation and higher doses to dysphagia/ aspiration related 
structures (DARS) (Eisbruch et al., 2004; Langendijk et al., 2009; Machtay et al., 2008). 
However, there is still mixed results regarding the risk factors correlating with swallowing 
functions. While a higher doses to DARS has been found to correlate with more severe 
dysphagia symptoms in some studies (Eisbruch et al., 2007; Feng et al., 2007), such correlation 
cannot be found in Bhide et al. (2009).  Batth, Caudell, and Chen (2014) suggested in their 
review paper that such variability can be accounted for by the different outcome measures used 
in the studies. While some studies used patient-reported questionnaires as the sole outcome 
measure, some used observer-rated measures or instrumental methods such as videofluoroscopy. 
Hence, to better assess the swallowing outcomes after radiotherapy, multidimensional data 
should be collected. In summary, despite the wealth of research looking into the swallowing 
outcome in head and neck cancer survivors and nasopharyngeal cancer survivors, there is a 
paucity of study which evaluates survivor’s multidimensional swallowing outcomes in one study. 
In light of this, the current study aims to investigate long-term swallowing functions in NPC 
survivors using a multidimensional assessment protocol based on the International Classification 
of Functioning, Disability and Health (ICF) framework. The International Classification of 
Functioning, Disability and Health framework provides a multidimensional framework in which 
the swallowing problem can be described. In the framework, dysphagia can be described by the 
two domains: (i) body functions and structures and (ii) activity and participation. 
Also, subjects in previous studies mostly included a heterogeneous group of head-and-
neck cancer survivors, including a small number of NPC survivors. However, some other studies 
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have demonstrated that the primary tumor localization was correlated with swallowing outcomes 
(Caglar et al., 2008; Dirix et al., 2009). Hence, study on the effect of radiotherapy on swallowing 
functions should be conducted specifically for each cancer type instead of head and neck cancer 
in general. Hence, the current study aims to identify the swallowing problems in nasopharyngeal 
cancer survivors specifically.  
In addition, although information on the swallowing functions after radiotherapy was 
plenty, most studies did not look into the long-term swallowing function in nasopharyngeal 
cancer survivors. Previous study has investigated that short-term swallowing outcomes by 
evaluating head and neck cancer survivors 4-8 weeks after radiotherapy (Caglar et al., 2008). 
Other studies looking into swallowing outcomes in head and neck cancer survivors have 
evaluated swallowing functions within 24 month after therapy (e.g. Dornfeld et al., 2007; 
Schwartz et al., 2010). Although Dirix, Abbeel, Vanstraelen, Hermans, and Nuyts (2009) have 
investigated swallowing functions of 53 hand and neck cancer survivors for up to 44.9 month 
after radiotherapy, they studied survivors with different cancer types and hence NPC-specific 
data was lacking.  Information on the long-term dysphagia symptoms is important from a clinical 
perspective as it provides invaluable information for the long-term management of dysphagia in 
nasopharyngeal cancer survivors.  In view of this, the current study also aims to look into long-
term swallowing functions in NPC survivors.  
 Hence, in light of the lack of data of   long-term, NPC specific and multidimensional 
swallowing functions after radiotherapy, the first objective of the study was to identify long-term 
swallowing functions  in nasopharyngeal cancer survivors using a multidimensional assessment 
protocol. To better understand if the swallowing outcomes were associated with the demographic 
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or treatment-related factors, the second objective was to identify factors which might be related 
to the long-term swallowing outcomes.  
Method 
Participants 
Twenty-seven nasopharyngeal cancer (NPC) survivors treated successfully with 
radiotherapy with or without chemotherapy were recruited in the study. Eleven males and 16 
females with a mean age of 57.6, ranged from 47 to 68 (SD = 6.74) were recruited. Only 
participants who have finished radiotherapy and/ or chemotherapy treatment for at least one year 
were recruited to avoid acute symptoms and to assess their long-term swallowing functions. To 
better assess treatment-related swallowing difficulties, survivors who have pre-treatment 
swallowing difficulty or other concomitant neurological or cognitive problems were excluded 
from the study. Table 1 shows the treatment-related factors for the participants.  
 
Table 1.  
Treatment-related factors of the participants. 
Treatment-related factors NPC survivors (n=27) 
Range of time since completion of radiotherapy (in 
years), mean (SD) 
2-28, 10.91 (6.65) 
Concurrent chemotherapy  
with concurrent chemotherapy 10 
without concurrent chemotherapy 17 
Concurrent surgical intervention  
with concurrent surgical intervention 5 
without concurrent surgical intervention 22 
 
Procedures 
 Demographic data and treatment related factors were collected. The participant’s 
swallowing abilities were then evaluated with the following procedures: (a) oromotor 
assessment, (b) participant-rated quality-of-life questionnaire and (c) fiberoptic endoscopic 
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evaluation of swallowing (FEES) and (d) a clinician-rated functional scale. Patients were 
evaluated with different order in the procedures.  
Oromotor assessment.  The client’s oromotor abilities were assessed by a speech 
therapist. Strength, range of movement and coordination of jaw, lips and tongue were rated on a 
6-point scale. A score of 0 represents severely impaired function and 5 represented non-impaired 
function. A composite score for each oromotor structure was obtained by averaging the scores in 
strength, range of movement and coordination. This outcome corresponds to the body functions 
and structures level in the ICF framework.  
Fiberoptic Endoscopic Evaluation of Swallowing (FEES). The participant’s 
swallowing ability was assessed using FEES. FEES provides a clear view of the hypopharynx 
and larynx during swallow which are valuable in evaluating the pharyngeal phase of swallow 
(Langmore, Schatz, & Olsen, 1988). Aspiration or penetration, or other related parameters such 
as amount of residue after swallow can be observed using FEES. During the assessment, each 
participant sat upright on a chair. Using the Wolf's Medical High Definition Endocam (Richard 
Wolf 5509, Knittlingen), a trained speech therapist inserted a flexible laryngoscope through the 
nasal cavity to the pharyngeal area until the laryngeal area was visualized. Each participant was 
fed at least one teaspoon (5ml) on each of the three consistencies: thin liquid, mildly thick liquid 
(100ml liquid with three standard spoonful of the thickener RESOURCE○R E A THICKENUP A○R E A and 
extra thick liquid (100ml liquid with five standard spoonful of the thickener RESOURCEA○R E A 
THICKENUP A○R E A). The three different consistencies were coloured differently with food dye to 
ensure there were clear distinctions between the trials. Degree of penetration or aspiration was 
rated using the Penetration-Aspiration Scale (Rosenbek, Robbins, Roecker, Coyle, & Wood, 
1996) .The approximate amount of bolus (in %) that remained on the valleculae or in the 
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pyriform sinuses were measured. Both the P-A scale and residue estimate corresponds to 
swallowing outcomes in the body functions and structures level in the ICF framework.  
The Penetration-Aspiration Scale (P-A scale). All swallowing trials were rated on the P-
A scale by two speech therapists. The P-A scale is an eight-point equal appearing scales for 
evaluation the degrees of penetration and aspiration, with higher rating corresponding to a more 
severe penetration/ aspiration status. The scale evaluates not only the depth of penetration or 
aspiration during swallow but also participant’s ability to remove the penetrated/ aspirated 
materials (Rosenbek et al., 1996). Both raters rated the P-A scale on the video of the endoscopic 
examination after the video have been encoded with participants numbers so they were blind to 
their other information during the ratings.  
 Percentage of bolus residing in valleculae or pyriform sinuses. On each swallowing 
trial, the approximate percentage of bolus residing in the valleculae or the pyriform sinuses were 
measured by the speech therapist. This factor was measured because disorders in the pharyngeal 
phase which can lead to residue in valleculae and pyriform sinuses have been reported in head 
and neck cancer survivors after treatment (Murphy & Gilbert, 2009). Also, pharyngeal reside has 
been reported as a predictor for aspiration for head and neck cancer survivors (Eisenhuber et al., 
2002).  
 Clinician-rated measure. The Functional Oral Intake Scale was used as the clinician-
rated scale for each client. The FOIS is a valid and reliable measure of the functional aspect of 
the participant’s current diet (Crary, Mann, & Groher, 2005).  It is a clinician-rated seven-point  
scale with one corresponding to nothing by mouth and seven corresponding to total oral diet with 
no restrictions. The speech therapist rated each participant using the scale based on the 
participant’s current diet. This measure corresponds to the activity level in the ICF framework.  
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Self-reported quality of life questionnaire.  All participants were asked to complete the 
M.D. Anderson Dysphagia Inventory (Chen et al., 2001). The questionnaire was used to assess 
the swallowing-related functioning and disability of the participants. The M.D. Anderson 
Dysphagia Inventory (MDADI) is a reliable and validated dysphagia-specific quality-of-life 
(QOL) questionnaire which contains 20 questions separated into four subscales including global, 
physical, functional and emotional subscale. The global subscale measures the overall QOL 
affected by dysphagia. Physical subscale measures survivor’s self-perception of swallowing 
difficulty relating to performing swallowing related tasks. Functional subscale measures the 
impact on daily activities brought by dysphagia. Emotional subscale measures the emotional 
response of the survivor towards his/her dysphagia. Each question is rated on a five-point scale. 
The score obtained in each scale will be summed up and translated to a score ranging from 0 to 
100, with a score of 100 indicating high functioning and a score of 0 representing extremely low 
functioning.   
 The four scales were categorized to different domains in the ICF framework for 
describing the swallowing functions in the two domains. The MDADI emotional subscale 
measured emotional response of the participants and hence it represented functions in the 
subcomponent ‘Specific Mental functions’ under the body functions and structures domains in 
the framework. The MDADI global, physical and functional scale measured the participants’’ 
ability to perform swallowing-related task and participate in life-events and hence they 
represented functions under the activity and participation domains.  
Data Analysis 
 Gender, age, number of years after radiotherapy and involvement of chemotherapy 
during radiotherapy treatment were the independent variables in the study. Swallowing-related 
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outcome measures included: (i) oromotor ability, (ii) the Penetration-Aspiration scale, (iii) 
Percentage of bolus residing on valleculae and pyriform sinuses (iv) Functional Oral Intake 
Scales and (v) MDADI scores. For comparison of swallowing outcomes between categorical 
groups (i.e. gender and involvement of chemotherapy) on the swallowing outcomes, Mann-
Whitney U test was used. Correlation between the time since completion of treatment and the 
swallowing outcomes were conducted using the Spearman rho rank order correlation. Non-
parametric tests were used due to the small sample size in the current study. The significance 
level was set at 0.05. Intraclass correlation (ICC) was used to measure the interrater reliability in 
rating the P-A scale. Both raters were asked to re-rate 20% of the data and the intra-rater 
reliability was also measured using the intraclass correlation.  
Results 
Reliability in P-A ratings 
 Based on the suggested interpretation of intraclass correlation in Landis and Koch (1977), 
ratings for P-A scale showed good reliability [ ICC (2, 1) = .696, p < .001] in thin liquid and 
good-to-perfect reliability [ ICC (2,1) = .856, p < .001] in mildly thick liquid and  good 
reliability [ ICC (2,1) = .775,  p < .05 ] in extra thick liquid. Intra-rater reliability for the ratings 
on different consistencies of fluid is shown in Table 2. The intra-rater reliability ranged from 
good to extremely good (.762-1.00). 
 
Table 2.  
Intra-rater reliability as measured in ICC coefficient for rating P-A scale on different fluid trials 
Swallowing Trials Rater A Rater B 
Thin Liquid .762 .762 
Mildly Thick Liquid 1.00 .980 
Extra Thick Liquid .980 .960 
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Long-term swallowing functions after radiotherapy 
 The results indicated that the participants’ dysphagia manifested in different domains in 
the ICF model. The swallowing functions of NPC survivors in the two domains will be described 
accordingly as follows.  
Body functions and structures domain.  Outcome measures of oromotor ability, the 
Penetration-Aspiration Scale, percentage bolus residing on valleculae and pyrifrom sinuses after 
swallowing and the MDADI emotional scores corresponded to the body functions and structures 
level of measurement.  
For oromotor ability, one participant was noted to have jaw impairment (4.5 %) and eight 
participants (30.8%) had lips impairment.  Twelve participants (50%) had impairment in tongue. 
Overall, 10 participants (47.6%) has impairment in at least one of the oromotor structures. 
Based on the P-A scale, 18 participants showed no sign of penetration on thin liquid 
(72%), six participants (24%) penetrated on thin liquid and one participant aspirated on thin 
liquid (4%). On mildly thick liquid, 17 participants (73.9%) showed no signs of penetration, and 
five participants (25.1%) had penetration. No participant had aspiration on mildly thick liquid. 
On extra thick liquid, sixteen participants (84.2%) showed no sign of penetration, whereas three 
participants (15.8%) had penetration. No participant aspirated on extra thick liquid. Taking all 
trials into consideration, 11 participants (45.8%) had penetration in at least one of the swallowing 
trials. Not all swallowing trials could be rated as some views were blocked during the 
swallowing trials. 
 The percentage of bolus residing on valleculae and pyriform sinuses was evaluated. All 
participants have pharyngeal residue in valleculae in at least one swallowing trial. Eighteen of 
the participants (81.8%) who have been rated in this parameter have pharyngeal residue in 
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pyriform sinuses at least one of the trials. Table 3 shows the range, mean and standard deviation 
of the results in this outcome.  
Table 3.  
Percentage of bolus residing on valleculae and pyriform sinuses^ 
Oral Trials  Range M (SD) 
Thin liquid  Percentage of bolus 
residing on valleculae 
(%) 
0-100 23.0(27.3) 
Percentage of bolus 
residing on pyriform 
sinuses (%) 
0-75 23.3(28.1) 
Mildly thick liquid  Percentage of bolus 
residing on valleculae 
(%) 
0-60 23.9(19.9) 
Percentage of bolus 
residing on pyriform 
sinuses (%) 
0-95 21.4(27.5) 
Extra Thick Liquid  Percentage of bolus 
residing on valleculae 
(%) 
5-100 54.7(31.1) 
Percentage of bolus 
residing on pyriform 
sinuses (%) 
0-50 10.7(16.3) 
^ not all participants has been rated in all swallowing trials as the view was blocked for 
some trials 
As for MDADI emotional scale, the scores ranged from 20 to 80, with a mean score and 
standard deviation of 56.2 and 17.1 respectively. The highest score possible was 100 which 
represents high functioning, and the lowest score possible was 0 which represents extremely low 
functioning (Chen et al., 2001). The mean score hence represented a moderate functioning in the 
scale.  
Activity and participation domain Outcome measures of Functional Oral Intake Scale 
and the MDADI physical scale corresponded to the activity level of measurement. The 
distribution of FOIS rating of the participants is shown in Table 4. Five participants were having 
non-oral diet (18.5%). The majority of the participants (44.4%) were having oral diet with 
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specific food limitations.  The mean and standard deviation for FOIS score was 5.19 and 1.91 
respectively. The scores for the MDADI physical scale ranged from 23 to 75, with a mean score 
of 53.6 ( SD = 15.7). The mean score represented a moderate functioning in the scale. 
Table 4.   
Number of participants in each level on the FOIS (scale adapted from Crary et al., 2005) 
Level Description Number of participants 
1 Nothing by mouth. 3 
2 Tube dependent with minimal attempts of food or 
liquid 
1 
3 Tube dependent with consistent oral intake of food or 
liquid 
1 
4 Total oral diet of a single consistency 0 
5 Total oral diet with multiple consistencies, but 
requiring special preparation or compensations 
4 
6 Total oral diet with multiple consistencies without 
special preparation, but with specific food limitations 
12 
7 Total oral diet with no restrictions.  6 
 
Outcome measures in MDADI global and functional scale corresponds to the 
participation level measurement. The MDADI global score ranged from 20 to 80 with mean 
score and standard deviation of 42.2 and 20.3 respectively. For the MDADI functional scale, the 
score ranged from 36 to 80 with a mean score of 56.4 (SD = 14.6). The mean scores for both 
global and functional scale also represented a moderate function.  
Factors Affecting Swallowing Outcomes 
 Table 5 shows the mean score and standard deviation in the outcome measures for 
different groups. For comparison of score across ages, three age groups were arbitrarily set for 
showing the mean score in the outcome measures across age.  
Relationships between independent variables and swallowing outcomes. Participants 
who had chemotherapy had significantly lower degree of penetration as shown from the P-A 
score for mildly thick liquid [U = 36.0, p < .05 , r = .46], and less residue for extra thick liquid  
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[U = 15.0, p < .05, r = .50]. Participants with concurrent chemotherapy did not differ 
significantly in number of years since radiotherapy [U = 57.0, ns, r = .27] and age [ U = 50.5, ns, 
r = .34] from participants without concurrent chemotherapy.  
 Number of years since completion of radiotherapy was positively correlated with degree 
of penetration for thin liquid [ rs (25) = .633, p < .01] , mildly thick liquid [ rs (23) = .415, p < .05] 
and residue at valleculae for extra thick liquid [ rs (18) = .548, p < .05]. Also, the number of years 
since completion of radiotherapy was negatively correlated with the MDADI global scale score 
[ rs (27) = -.382 , p < .05] and MDADI physical scale score [ rs (27) = -.4.17 , p < .05]. 
 Regression analysis indicated that the number of years since completion of radiotherapy 
significantly predicted the percentage of bolus residing on valleculae in extra thick liquid trials,  
β = .574, t(16) = 2.80, p < .05, with higher number of years since completion predicting more 
valleculae residue for extra thick liquid. It explained a significant proportion of variance in the 
outcome, R2 = .329, F (1, 16) = 7.86, p < .05.  
Relationships among dependent variables. Correlation between the outcome measures 
was also assessed. P-A scale in thin liquid was found to be positively correlated with the 
percentage of bolus residing on pyriform sinuses in oral trials on thin liquid [ rs (20) = .503, p 
< .05].  
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Table 5.  
Outcome measures in different groupings 
Groups  Body functions and structures domains parameters 
  OMComp^ MDADI E+ PAthin+ PAmild+ PAextra+ 
  M (SD) M (SD) M (SD) M (SD) M (SD) 
Gender Male  3.74 (1.02) 55.8 (13.1) 2.36 (2.24) 2.36 (2.25) 1.50 (1.23) 
Female  4.30 (.79) 56.5 (19.8) 1.50 (1.09) 1.50 (1.09) 1.31 (.855) 
Age 
Group 
Below 
50  * 54.4 (25.0) 2.00 (1.73) 2.00 (1.73) 1.33 (.577) 
51-60  3.87 (.950) 56.7 (15.1) 1.40 (.910) 1.31 (.855) 1.30 (.949) 
61-70  4.51 (.673) 55.9 (19.8) 2.86 (2.67) 2.00 (1.53) 1.50 (1.24) 
CT with 
CT  4.13 (.956) 61.0 (13.2) 1.60 (1.075) 1.00 (.000) 1.00 (.000) 
without 
CT  4.05 (.914) 53.3 (18.8) 2.07 (2.05) 1.93 (1.39) 1.58 (1.17) 
^ for simplicity, a composite score (OMComp) for the oromotor ability in lips, jaw and tongue was obtained by averaging the scores in 
the three oromotor structures. 
* missing value as participants could not complete the full assessment   
+MDADIE: Emotional scale of MDADI; PAthin: P-A scale for thin liquid trials; PAmild: P-A scale for mildly thick liquid trials; 
PAextra: P-A scale for extra thick liquid trials.  
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Table 5.  
(continued) Outcome measures in different groupings 
Groups  Body functions and structures 
Level Parameters (Continued) 
Activity Level Parameters Participation Level Parameters 
  %Resid(V) + %Resid(P) + FOIS MDADIP+ MDADIG+ MDADI F+ 
  M (SD) M (SD) M (SD) M (SD) M (SD) M (SD) 
Gender Male  31.4 (15.5) 24.6 (31.8) 4.70 (2.00) 55.0 (13.6) 38.2 (18.9) 52.4 (13.9) 
Female  30.9 (18.7) 8.33 (10.9) 5.80 (1.47) 52.7 (17.4) 45.0 (21.3) 59.3 (14.8) 
Age 
Group 
Below 50  22.2 (5.09) 11.7 (16.5) 6.00 (1.00) 51.7 (23.6) 46.7 (30.6) 53.3 (18.0) 
51-60  32.3 (18.62) 11.1 (12.0) 5.15 (1.91) 52.0 (13.6) 38.7 (16.0) 56.0 (12.5) 
61-70  34.0 (19.2) 29.7 (39.8) 5.44 (1.81) 56.9 (17.8) 46.7 (24.5) 58.2 (18.1) 
CT with CT  24.0 (14.3) 10.8 (13.2) 5.33 (2.00) 57.3 (11.6) 48.0 (19.3) 59.6 (14.0) 
without 
CT  35.6 (17.7) 21.7 (30.7) 5.38 (1.67) 51.5 (17.7) 38.8 (20.6) 54.6 (15.0) 
+ %Resid(V): percentage of bolus residing on valleculae; %Resid(P): percentage of bolus residing on pyriform sinuses; MDADIP: 
Physical scale of MDADI; MDADIG: Global scale of MDADI; MDADIF: Functional scale of MDADI 
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Discussion 
 The first objective of the study was to identify long-term swallowing functions in 
nasopharyngeal survivors after radiotherapy or chemo-radiation. The following discusses the 
swallowing functions and ability in the two domains in ICF. Following discussion of the long-
term swallowing problems and the possible pathophysiology, factors which are correlated with 
swallowing outcome and their implication will be discussed.  
Long-term swallowing functions in nasopharyngeal cancer survivors.  
 Body functions and structures domain. Oromotor deficits, penetration or aspiration and 
pharyngeal retention were common in participants in the current study, occurring in 47.6%, 
45.8% and all participants respectively. Impairment in tongue function was the most common 
oromotor deficit, which occur in half of the participants. Previous study has reported tongue 
atrophy in 54.8% of head and neck cancer survivors (see review by Manikantan et al., 2009). 
They suggested that the sequalae of radiation mainly arouse from the tissue change in the head 
and neck region upon radiation, which is directly related to the dosimetry of the radiation. Other 
study also suggested that radiotherapy can lead to fibrosis in the head and neck region (Cooper, 
Fu, Marks, & Silverman, 1995), and hence this may be a possible explanation to the oromotor 
deficits in the current study. Another possible pathophysiology might be cranial nerve palsy. 
Since swallowing-related structures are controlled by cranial nerves, damage on the cranial 
nerves induced by radiation might lead to oromotor deficits. For nasopharyngeal cancer 
survivors, cranial nerve palsy which can lead to oromotor dysfunctions has been reported for all 
three participants in Mok, Seshadri, Siow, and Lim (2001)’s study. In light of these, there were 
different hypotheses to explain the observed impairment in the current study, hence the 
pathophysiology remains to be an area which requires further investigation.   
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The incidence for penetration or aspiration was common as reflected in the P-A scale. 
Pharyngeal retention was also prevalent dysphagic symptoms among the participants. Positive 
correlation between percentages of bolus residing on pyriform sinuses on thin liquid and P-A 
score indicated that the residue might be a risk factor for penetration or aspiration. Pharyngeal 
retention has also been reported in nasopharyngeal cancer survivors in previous study (Wu, 
Hsiao, Ko, & Hsu, 2000) in which a correlation between pharyngeal retention and post-swallow 
aspiration was also found. Examination of the percentage of bolus residing shows that a large 
proportion (M = 54.7% ) of the bolus was retained in the valleculae after swallow for extra thick 
liquid, indicating a specific difficulty in swallowing thicker fluid. Possible pathophysiology to 
the pyriform sinus residue might be an impaired pharyngeal bolus transition and inadequate 
upper esophageal sphincter (UES) relaxation (Dodds, Logemann, & Stewart, 1990; Manikantan 
et al., 2009). For head and neck cancer survivors, this impairment in pharyngeal constrictor 
muscles have been reported in Eisbruch et al. (2004). Since the pharyngeal constrictors were 
adjacent to the tumor localization for head and neck cancer, the pharyngeal constrictors might be 
exposed to a high dose of radiation during radiotherapy. Previous study has demonstrated that 
radiation dose to the pharyngeal constrictors is positively correlated with impairment in 
swallowing in head and neck cancer survivors (Eisbruch et al., 2007; Feng et al., 2007). Hence, 
the observed impairment in the pharyngeal phase of swallow might also be associated with 
dosage during radiotherapy.  
On an emotional aspect, the client showed moderate function as reflected in the MDADI 
emotional score. However, large variation in the score was noted which indicated that the 
manifestation of swallowing outcome in the emotional aspect varied across survivors.  
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 Activity and participation domain.  The FOIS and scores on MDADI physical scale are 
outcome measures corresponding to the activity domains. The results indicated that diet 
alternation was common.  From the FOIS rating, five participants (18.5%) in our study were 
tube-dependent survivors whereas others were having oral diet with or without restrictions. 
However, the majority of the participants (44.4%) are having oral diet with specific food 
limitations. This indicated that there was a wide range of functional outcome in terms of their 
current diet. For the MDADI physical scale, the participants on average have a moderate 
function in the scales. This suggested the participant's swallowing problem also manifest in 
limiting their day-to-day activity. However, it was also noted that variation in the MDADI score 
was large, indicating the participants' swallowing problem have limited their swallowing-related 
activity differently.  
 Scores in the MDADI global and functional scales corresponds to the participation 
domains. Overall, the participants also achieved a moderate functioning in the MDADI global 
and functional scales. Again, variation in the score was large, indicating that the swallowing 
problem have affected their participation in life-events or social activities.  
Factors correlating with the swallowing outcomes  
 Although long-term swallowing disabilities were identified, many variations were noted 
in different outcome parameters across patients. The second objective of this study aims to 
identify factors which may be associated with the swallowing outcomes. The following 
described the associated factors and the possible hypothesis behind the association.  
 Number of years since completion of radiotherapy. The number of years since 
completion of radiotherapy was significantly correlated with swallowing outcomes in different 
domains.  In general, as the number of years since completion of cancer treatment increases, the 
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swallowing functions decreased in both the body functions and structures, and activity and 
participation domains. 
From a clinical perspective, the trend of general deteriorating functions in swallowing 
provided evidence to support continuous monitoring of swallowing functions in nasopharyngeal 
cancer survivors. This idea is also supported in a review paper by Rosenthal, Lewin, and 
Eisbruch (2006), in which assessments before, during and after the radiotherapy were 
recommended such that swallowing maneuvers and other therapeutic strategies can be suggested 
as soon as swallowing problem emerge. In light of the research evidence that postural change 
and swallowing maneuvers were effective in lowering aspiration risks (Logemann, Pauloski, 
Rademaker, & Colangelo, 1997; Rasley et al., 1993), this continuous management and 
introduction of suitable therapeutic strategies at an early stage is very important for better 
prognosis in terms of their swallowing functions.  
 From a research perspective, the deteriorating swallowing function is a proponent to urge 
for further research to identify reasons behind the deterioration and ways to prevent or minimize 
the deterioration. The utmost research questions would be the pathophysiology behind the 
deterioration in functions with time and whether it can be prevented or minimized, and then the 
way through which can be done. Some studies have already provided possible explanation to the 
pathophysiology of the deterioration. Previous paper by Murphy and Gilbert (2009) suggested 
that the chronic deprivation of oxygen, and imbalance in the production and detoxification of 
free radicals which lead to tissue damage can happen after a long time of radiotherapy treatment. 
These processes may cause long term deterioration in swallowing-related structures and hence 
the longer the radiotherapy has been completed, the worse the swallowing outcome would be. 
Empirical evidence of structural change in swallowing structure with time after radiotherapy has 
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been documented in a prospective study by Eisbruch et al. (2004), who have also shown that 
such change was likely related to the swallowing functions. Hence, the next research question 
would be to identify the factors which can affect the processes and whether they can be altered to 
minimize long-term swallowing deterioration.  
Concurrent chemotherapy. From the analysis, participants treated with chemotherapy 
had significantly lower degree of penetration in oral trials on mildly thick liquid and less residue 
on valleculae for extra thick liquid than participants without chemotherapy.  Comparison 
between the two groups indicated that the two groups did not differ significantly in age or 
number of years since completion of radiotherapy, suggesting that the involvement of 
chemotherapy concurrent with the radiotherapy might be the main factor associated with the 
swallowing outcomes. Similar to the current findings, the predictive value of concurrent 
chemotherapy has been reported in head and neck cancer survivors (De Ruyck et al., 2013). 
However, the current study found an opposite trend to the study conducted by Caudell et al. 
(2009) . Since the study population in Caudell et al. (2009) was head and neck cancer survivors, 
the difference in the direction of relationship raised the questions on whether concurrent 
chemotherapy have different association with different types of head and neck cancer survivors. 
Although the current study has provided further evidence that concurrent chemotherapy is 
associated with the chronic swallowing outcome, further investigation is needed to how 
chemotherapy may be related to swallowing outcomes and whether they have different 
associations for different cancer types.  
Limitations and further study 
 One limitation on the current study is the lack of treatment details for each participant. As 
explained, emerging evidence is suggesting that dose to swallowing-related structures are 
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correlated with swallowing outcomes in head and neck cancer survivors. It is possible that such 
factor is also associated with swallowing outcome in nasopharyngeal cancer survivors. Hence, 
investigation into the effect of demographic variables should be done alongside with detailed 
treatment variables. Treatment details such as the treatment modality, treatment technique, 
dosage, and duration of the therapy can be further investigated to identify if any specific 
parameters may be associated with swallowing outcomes.  
Another limitation of the current study is that prospective evaluation of swallowing 
functions was not conducted. This limitation may affect the interpretation of the observed 
deteriorating swallowing functions with time.  It is difficult to isolate whether the observed trend 
was attributable solely to the time change due to within subject function deterioration or between 
subject factors.  One prominent between subject factors which may be associated with the time-
changing swallowing function is the difference in treatment strategy in radiotherapy. Different 
radiotherapy planning techniques have been used to treat NPC in the past, namely 2-dimensional 
radiotherapy (2DRT), conventional 3-dimensional conformal radiotherapy (3DCRT) and 
intensity-modulated radiotherapy (IMRT). Among the various types of radiotherapy, IMRT is 
becoming more widely used for treating head and neck cancer over conventional 2DRT and 
3DCRT in recent years (Bucci, Bevan, & Roach, 2005), because IMRT has recognized better 
target coverage and sparing of normal organs. IMRT has also been used  since a clinical 
investigation in the 2000s in Hong Kong and promising results for loco-regional control was 
presented (Kam et al., 2004). Advantage in swallowing-related outcome has been reported. 
IMRT can, for example, induce less severe xerostomia and reduced the penetration or aspiration 
(Kam, Chau, Suen, Choi, & Teo, 2003; Mortensen, Jensen, Aksglaede, Behrens, & Grau, 2013; 
Vergeer et al., 2009; Xia, Fu, Wong, Akazawa, & Verhey, 2000). Hence, it is likely that the trend 
CHRONIC SWALLOWING FUNCTIONS AFTER RADIOTHERAPY                                     22 
 
found in this study can be affected by the improvement in radiotherapy technique. In light of this, 
further study on factors associating with swallowing outcome should involve prospective 
evaluation of swallowing outcome with collection of treatment-related factors. Upon 
identification of factors associated with long-term dysphagia, NPC survivors prone to long-term 
dysphagia might be easier to identify and hence early intervention for at-risk groups can be 
provided.   
Despite the need to further investigate the factors associated with long-term swallowing 
outcomes such that early identification is possible, there is a also strong need to investigate ways 
through which the swallowing dysfunctions could be minimized. Reduction of doses to certain 
structures seems to be a promising direction (Eisbruch et al., 2004). In view of the capability of 
IMRT in sparing more normal organs, studies are steering to identify ways to optimize 
radiotherapy for better swallowing outcomes. For example, emerging evidence suggests that 
dose to certain swallowing-related structures are significantly correlated with swallowing 
difficulties (Feng et al., 2007; Levendag et al., 2007) Hence, further research direction should 
also focus on whether modification to treatment parameters such as dosage can reduce long-term 
swallowing problems in nasopharyngeal cancer survivors with multidimensional evaluation of 
swallowing functions. Also, after specific factors which are associated with long-term 
swallowing outcome are identified, alteration to the specific parameters, if feasible, might also 
help optimize swallowing outcomes. Yet, this should also be investigated further in prospective 
studies.  
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Conclusion 
 This study showed that long-term swallowing problems were prevalent in nasopharyngeal 
cancer survivors. Oromotor deficits, penetration or aspiration and pharyngeal retention were 
common long-term swallowing problems. The swallowing problems also manifested in limiting 
their day-to-day activities and participation in life events, though large variation in functioning 
was noted. Further analysis indicated that radiotherapy concurrent with chemotherapy was 
associated with lower degree of penetration and less pharyngeal retention than radiotherapy 
alone. Correlation analysis  showed that the degree of penetration, pharyngeal retention increased 
with time since completion of radiotherapy and functioning in the activity and participation 
domains decreased with time since completion of radiotherapy. The results indicated that 
continuous monitoring of swallowing functions is necessary for nasopharyngeal cancer survivors. 
Further research is needed to identify other factors which are associated with swallowing 
outcomes such that early identification of at-risk survivors is feasible. Also, further research on 
ways to minimize long-term swallowing problems should be conducted.   
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